Skip to main content

Table 1 Demographics and outcomes (n = 103 subjects)

From: Underdiagnoses of Rickettsia in patients hospitalized with acute fever in Indonesia: observational study results

Median age (range) y.o.

35 (1–75)

Male: female

69: 34

Distribution of cases in age groupa, N(%)

 1 - ≤5 years

2/153 (1.3%)

 6 - ≤18 years

19/190 (10%)

 19 - ≤45 years

53/378 (14%)

 > 45 years

29/254 (11.4%)

Day of onset (median, range), days

5 (1–12)

Length of stay (median, range), days

6 (1–36)

Antibiotics use from 90 subjects with documented history, N (%)

76 (84%)

 Ceftriaxone

17 (22.4%)

 Ciprofloxacin

9 (11.8%)

 Levofloxacin

9 (11.8%)

 Cefixime

2 (2.6%)

 Cefotaxime, Amoxicillin, Ampicillin, Cefadroxil, Meropenem, Chloramphenicol, Cefoperazone, Sulbactam, Cotrimoxazole

1 (1.3%), each

 Combination 2–3 antibiotics

30 (39.5%)

Outcomes, N (%)

 Recovered

72 (69.9%)

 Recovered with sequelaeb

24 (23.3%)

 Died

7 (6.8%)

By sitesa, N (%)

 Bandung

22/189 (11.6%)

 Denpasar

16/101 (15.8%)

 Jakarta

7/87 (8%)

 Makassar

5/131 (3.8%)

 Semarang

21/191 (10.9%)

 Surabaya

26/156 (16.7%)

 Yogyakarta

6/120 (5%)

  1. afrom 975 subjects tested for Rickettsia typhi
  2. bLethargy, arthralgia, anorexia, headache, dizziness, cough